Selective modulation of microglial signal transduction by PACAP

Heasuk Lee1, Kyoungho Suk

  • 1Department of Pharmacology, School of Medicine, Kyungpook National University, #101 Dong-In, Joong-gu, Daegu, 700-422 Korea.

Neuroreport
|June 15, 2004
PubMed

Insights

Pituitary adenylate cyclase-activating polypeptide (PACAP) reduces inflammatory responses in mouse microglia cells. PACAP inhibits nitric oxide production and inflammatory gene expression by modulating specific signaling pathways.

Area of Science:

  • Neuroimmunology
  • Cellular signaling
  • Molecular biology

Background:

  • Microglia play crucial roles in neuroinflammation.
  • Pituitary adenylate cyclase-activating polypeptide (PACAP) is a neuropeptide with known immunomodulatory functions.
  • Understanding PACAP's effects on microglial inflammatory pathways is essential for neuroinflammatory disease research.

Purpose of the Study:

  • To investigate the impact of PACAP on inflammatory signaling pathways in BV-2 mouse microglia cells.
  • To elucidate the specific molecular mechanisms underlying PACAP's anti-inflammatory effects.

Main Methods:

  • BV-2 mouse microglia cells were pretreated with PACAP.
  • Cells were stimulated with lipopolysaccharide (LPS) or interferon-gamma (IFN-gamma).
  • Nitric oxide (NO) production, inducible nitric oxide synthase (iNOS) and Interleukin-1 beta (IL-1beta) mRNA levels, and key signaling pathway activations (p38 MAPK, ERK, JNK, NF-kappaB, STAT-1, IRF-1) were assessed.

Main Results:

  • PACAP pretreatment significantly decreased LPS- or IFN-gamma-induced NO production.
  • PACAP reduced iNOS and IL-1beta mRNA levels.
  • PACAP's inhibitory effect was linked to increased intracellular cyclic adenosine monophosphate (cAMP).
  • PACAP specifically inhibited LPS-induced p38 mitogen-activated protein kinase (MAPK) activation, without affecting ERK, JNK, or NF-kappaB.
  • IFN-gamma-induced STAT-1 activation and IRF-1 induction were not significantly influenced by PACAP.

Conclusions:

  • PACAP suppresses inflammatory activation in BV-2 microglia.
  • The anti-inflammatory effects of PACAP are mediated through increased intracellular cAMP.
  • PACAP specifically inhibits the LPS-induced p38 MAPK pathway in microglia, suggesting a targeted mechanism for controlling neuroinflammation.